alpharadin

This page shows the latest alpharadin news and features for those working in and with pharma, biotech and healthcare.

FDA clears Bayer/ Algeta's prostate cancer radiotherapy

Analysts have predicted that Xofigo (formerly known as Alpharadin) could achieve sales of $650m within three years of launch and more than $1bn a year at its peak if follow-up

Latest news

Bayer pins hopes on five potential blockbusters

Bayer pins hopes on five potential blockbusters. Riociguat, alpharadin, Stivarga, Eylea, and Xarelto expected to reach sales of 5.5bn by 2015. ... The German company's expectations are high for it yet to be approved riociguat and alpharadin (radium-223
FDA fast-tracks Bayer's prostate cancer radiotherapy

FDA fast-tracks Bayer's prostate cancer radiotherapy. Priority review for radium-223 dichloride, formerly called Alpharadin. ... The FDA granted priority review status to radium-223 dichloride - formerly called Alpharadin - for the treatment of
New hope for castration-resistant prostate cancer

Another bone-targeting agent in phase III trials of use in patients with CRPC and bone metastases is radium-223 chloride (Alpharadin; Algeta, Bayer Healthcare), a first-in-class, highly targeted
Developing drugs to conquer cancer

Bayer HealthCare discussed phase III results concerning regorafenib in gastrointestinal stromal tumour (GIST) and in colorectal cancer, as well as the final overall survival analysis of radium-223 (Alpharadin) data in
Bayer raises 2012 forecasts on increasing revenues

Bayer has previously highlighted four potential blockbusters in its late-stage pipeline, including Xarelto, Eylea (aflibercept) for wet age-related macular degeneration (AMD) and two cancer drugs, namely alpharadin for bone

More from news
Approximately 2 fully matching, plus 10 partially matching documents found.

Latest appointments

Bayer’s former oncology head Robert Rosen joins AP Pharma

Rosen also led premarket activities for Stivarga (regorafenib) in its indications for gastrointestinal stromal tumours and colon cancer, as well as for alpharadin in prostate cancer.
Former Bayer oncology head Robert Rosen joins AP Pharma's board

He was also involved in pre-market activities for regorafenib in the treatment of patients with gastrointestinal stromal tumours and colon cancer, as well as alpharadin for prostate cancer.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Account Manager: Negotiable

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Medical Writer - Creative and Scientific Projects: DOE

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Senior Writer, Healthcare Advertising, London: Excellent package

Associate Scientific Director: Salary TBC

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Graduate Scientific Editor: DOE

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Healthcare PR Senior Account Manager: Salary TBC

Account Manager- 4 days per week or full-time: Salary TBC

Senior Training Manager - Surrey: Competitive Salary &Bonus

Senior Medical Writer: Salary is DOE

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Healthcare PR Director: £100, 000 – £120, 000 benefits

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Account Director, Healthcare Advertising Agency: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Account Director or Senior Account Director: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

The gene therapy revolution: Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...